Similar medications and substitutes for EPCORITAMAB-BYSP
In short: Epkinly (EPCORITAMAB-BYSP) belongs to the Bispecific CD20-directed CD3 T Cell Engager class. The medications listed below either share that mechanism of action or have been clinically validated as substitutes when Epkinly is unsuitable due to side effects, cost, availability, or contraindications.
No alternatives are listed for Epkinly in our database yet. Browse the full medicine index or consult your pharmacist for substitution advice.